Physician
Garcia, Claudia
Garcia, Claudia was paid $2.39M by Medicaid between Jan 2018 and Dec 2024, across 54 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 25% of everything it billed.
33Billing provider infoGARCIA, CLAUDIA
HENDERSON, NV 89014
HENDERSON, NV 89014
33aNPI1457450017assigned 09/21/2006
33bProvider typePediatrics Physician
28Total paid$2.39M
24GClaims65,134
24DCodes billed54
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Nevada
Rank by total paid#24 of 267
Median peer was paid$116K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,282 | $424K | |
| 2019 | 8,410 | $302K | |
| 2020 | 8,467 | $288K | |
| 2021 | 8,132 | $313K | |
| 2022 | 11,822 | $413K | |
| 2023 | 10,433 | $401K | |
| 2024incomplete | 6,588 | $249K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 7,196 | 5,608 | $587K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 6,741 | 5,780 | $401K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 14% | 3,551 | 3,273 | $332K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 12% | 3,204 | 2,689 | $280K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 11% | 6,815 | 6,275 | $268K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.2% | 2,175 | 1,970 | $196K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.3% | 1,091 | 968 | $102K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 4.1% | 3,073 | 2,857 | $97K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 631 | 589 | $22K |
| 92567 | <1% | 2,008 | 1,678 | $21K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,893 | 1,673 | $15K |
| 94760 | <1% | 6,879 | 5,339 | $13K |
42 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 708 | $11K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 396 | $9K |
| 99058 | <1% | 454 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 479 | $6K |
| 87807 | <1% | 681 | $5K | |
| 99381 | <1% | 48 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 151 | $4K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 159 | $3K |
| 85018 | <1% | 1,926 | $3K | |
| 36416 | <1% | 2,538 | $967.70 | |
| 94664 | <1% | 92 | $909.63 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 573 | $871.05 |
| 90671 | <1% | 322 | $677.99 | |
| 90651 | <1% | 148 | $639.01 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 573 | $566.51 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 26 | $454.90 |
| 96127 | <1% | 73 | $273.80 | |
| 90700 | <1% | 657 | $92.92 | |
| 81002 | <1% | 51 | $91.72 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 12 | $88.43 |
| 84030 | <1% | 16 | $65.00 | |
| 99000 | <1% | 2,223 | $20.74 | |
| J7633 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram | <1% | 85 | $20.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 153 | $13.49 |
| J7610 | Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg | <1% | 182 | $2.97 |
| 90686 | <1% | 1,745 | $1.58 | |
| A4250 | Urine test or reagent strips or tablets (100 tablets or strips) | <1% | 14 | $0.12 |
| 90670 | 0% | 1,395 | $0.00 | |
| 90633 | 0% | 778 | $0.00 | |
| 90713 | 0% | 86 | $0.00 | |
| 90685 | 0% | 188 | $0.00 | |
| 90734 | 0% | 102 | $0.00 | |
| 90710 | 0% | 78 | $0.00 | |
| 90715 | 0% | 59 | $0.00 | |
| 90707 | 0% | 40 | $0.00 | |
| 90648 | 0% | 27 | $0.00 | |
| 90744 | 0% | 535 | $0.00 | |
| 90680 | 0% | 852 | $0.00 | |
| 90698 | 0% | 1,129 | $0.00 | |
| 90716 | 0% | 40 | $0.00 | |
| 90619 | 0% | 64 | $0.00 | |
| 97802 | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.